scispace - formally typeset
I

Irmgard Förster

Researcher at University of Bonn

Publications -  118
Citations -  18175

Irmgard Förster is an academic researcher from University of Bonn. The author has contributed to research in topics: Immune system & Proinflammatory cytokine. The author has an hindex of 47, co-authored 113 publications receiving 16317 citations. Previous affiliations of Irmgard Förster include Ludwig Maximilian University of Munich & Technische Universität München.

Papers
More filters
Journal ArticleDOI

Conditional gene targeting in macrophages and granulocytes using LysMcre mice.

TL;DR: The generation of mice that express Cre in myeloid cells due to targeted insertion of the cre cDNA into their endogenous M lysozyme locus is reported, allowing for both specific and highly efficient Cre–mediated deletion of loxP–flanked target genes in myELoid cells.
Journal ArticleDOI

HIF-1α Is Essential for Myeloid Cell-Mediated Inflammation

TL;DR: It is found that activation of HIF-1alpha is essential for myeloid cell infiltration and activation in vivo through a mechanism independent of VEGF, and its direct regulation of survival and function in the inflammatory microenvironment is demonstrated.
Journal ArticleDOI

Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils.

TL;DR: Taken together, Stat3 plays a critical role in deactivation of macrophages and neutrophils mainly exerted by IL-10, which contributes to chronic enterocolitis with age.
Journal ArticleDOI

SOCS3 negatively regulates IL-6 signaling in vivo.

TL;DR: It is shown that Socs3 deficiency results in prolonged activation of signal transducer and activator of transcription 1 (STAT1) and STAT3 after IL-6 stimulation but normal activation of STAT1 after stimulation with interferon-γ (IFN-γ).
Journal ArticleDOI

Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation

TL;DR: This article showed that type I interferon (IFN) inhibited interleukin-1 (IL-1) production through two distinct mechanisms: STAT1 transcription factor and autocrine IL-10 signaling.